Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

Noel G. McElvaney, Jonathan Burdon, Mark Holmes, Allan R. Glanville, Peter Wark, Philip J. Thompson, Paul Hernandez, J Chlumský, Helmut Teschler, Joachim H. Ficker,

The Lancet Respiratory Medicine · 2016 · 194 citations · 20 references

DOIFull text

Open access

Concepts

References

20